These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32380991)

  • 1. Influence of KISS1 gene polymorphisms on the risk of polycystic ovary syndrome and its associated variables, in Saudi women.
    Daghestani MH; Daghestani MH; Daghistani M; Ambreen K; Albalawi FS; AlNeghery LM; Warsy AS
    BMC Endocr Disord; 2020 May; 20(1):59. PubMed ID: 32380991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. rs4889 polymorphism in KISS1 gene, its effect on polycystic ovary syndrome development and anthropometric and hormonal parameters in Saudi women.
    Albalawi FS; Daghestani MH; Daghestani MH; Eldali A; Warsy AS
    J Biomed Sci; 2018 May; 25(1):50. PubMed ID: 29848339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of
    Daghestani MH; Daghestani MH; Daghistani M; Ambreen K; Almuammar MN; Al Neghery LM; Warsy AS
    Br J Biomed Sci; 2020 Oct; 77(4):185-190. PubMed ID: 32031919
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of Kiss1 and GPR54 Gene Polymorphisms with Polycystic Ovary Syndrome among Sri Lankan Women.
    Branavan U; Muneeswaran K; Wijesundera WSS; Senanayake A; Chandrasekharan NV; Wijeyaratne CN
    Biomed Res Int; 2019; 2019():6235680. PubMed ID: 30993114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of the KiSS-1 and GPR54 genetic polymorphism with polycystic ovary syndrome in Yunnan, China.
    Zhao T; Zhang Q; Xiao X; Tao X; Gao M; He W; Wu X; Yuan T
    Gynecol Endocrinol; 2022 Sep; 38(9):790-794. PubMed ID: 35903815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome.
    Deswal R; Nanda S; Dang AS
    Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of kisspeptin in the pathogenesis of a polycystic ovary syndrome.
    Aasif A; Alam R; Ahsan H; Khan MM; Khan A; Khan S
    Endocr Regul; 2023 Jan; 57(1):292-303. PubMed ID: 38127687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse Effects of Selected Markers on the Metabolic and Endocrine Profiles of Obese Women With and Without PCOS.
    Daghestani MH; Daghestani MH; Warsy A; El-Ansary A; Omair MA; Omair MA; Hassen LM; Alhumaidhi EM; Al Qahtani B; Harrath AH
    Front Endocrinol (Lausanne); 2021; 12():665446. PubMed ID: 34122339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An association between fat mass and obesity-associated (FTO) (rs9939609) and kisspeptin-1 (KISS-1) (rs4889, rs372790354) gene polymorphisms with polycystic ovary syndrome: an updated meta-analysis and power analysis.
    Stephen SB; Pauline R; Velmurugan S; Subbaraj GK
    J Assist Reprod Genet; 2024 Sep; 41(9):2457-2475. PubMed ID: 39126595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome.
    Lin S; Huiya Z; Bo L; Wei W; Yongmei G
    Endocrine; 2009 Dec; 36(3):503-9. PubMed ID: 19856137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome.
    Romero-Ruiz A; Skorupskaite K; Gaytan F; Torres E; Perdices-Lopez C; Mannaerts BM; Qi S; Leon S; Manfredi-Lozano M; Lopez-Rodriguez C; Avendaño MS; Sanchez-Garrido MA; Vazquez MJ; Pinilla L; van Duin M; Kohout TA; Anderson RA; Tena-Sempere M
    Hum Reprod; 2019 Dec; 34(12):2495-2512. PubMed ID: 31820802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicle Stimulating Hormone (LH: FSH) Ratio in Polycystic Ovary Syndrome (PCOS) - Obese vs. Non- Obese Women.
    Saadia Z
    Med Arch; 2020 Aug; 74(4):289-293. PubMed ID: 33041447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of elevated LH/FSH ratio in lean PCOS revisited: a path analysis.
    Pratama G; Wiweko B; Asmarinah ; Widyahening IS; Andraini T; Bayuaji H; Hestiantoro A
    Sci Rep; 2024 Apr; 14(1):8229. PubMed ID: 38589425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between single nucleotide polymorphism-56 of calpain-10 gene and glucose and lipid metabolism in polycystic ovary syndrome patients].
    Diao XH; Shi YH; Gao Q; Wang LC; Tang R; Chen ZJ
    Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):106-9. PubMed ID: 18683748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of electroacupuncture on the kisspeptin-gonadotropin-releasing hormone (GnRH) /luteinizing hormone (LH) neural circuit abnormalities and androgen receptor expression of kisspeptin/neurokinin B/dynorphin neurons in PCOS rats.
    Xu G; Zhao X; Li Z; Hu J; Li X; Li J; Chen Y
    J Ovarian Res; 2023 Jan; 16(1):15. PubMed ID: 36650561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kisspeptin Variations in Patients with Polycystic Ovary Syndrome-A Prospective Case Control Study.
    Akad M; Socolov R; Furnică C; Covali R; Stan CD; Crauciuc E; Pavaleanu I
    Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744039
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperactive LH Pulses and Elevated Kisspeptin and NKB Gene Expression in the Arcuate Nucleus of a PCOS Mouse Model.
    Esparza LA; Schafer D; Ho BS; Thackray VG; Kauffman AS
    Endocrinology; 2020 Apr; 161(4):. PubMed ID: 32031594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of
    Kadhem AH; Gholizadeh A; Khalaj-Kondori M
    J Int Med Res; 2023 Sep; 51(9):3000605231196837. PubMed ID: 37702549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MC4R variants rs12970134 and rs17782313 are associated with obese polycystic ovary syndrome patients in the Western region of Saudi Arabia.
    Batarfi AA; Filimban N; Bajouh OS; Dallol A; Chaudhary AG; Bakhashab S
    BMC Med Genet; 2019 Aug; 20(1):144. PubMed ID: 31429705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted inhibition of kisspeptin neurons reverses hyperandrogenemia and abnormal hyperactive LH secretion in a preclinical mouse model of polycystic ovary syndrome.
    Coutinho EA; Esparza LA; Rodriguez J; Yang J; Schafer D; Kauffman AS
    Hum Reprod; 2024 Sep; 39(9):2089-2103. PubMed ID: 38978296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.